Request Trial
15 December 2024NewsAmericasChristopher Sweeney Executive Director Acuitas Therapeutics, Alison Maddeford Director Litigation & Risk Management Thermo Fisher Scientific, Daniel Yarbrough Head of Intellectual Property Element Biosciences, Madhuri Roy Partner Cooley

WATCH: The challenge of protecting patents and innovation - obviousness-type double patenting post In re Cellect

Speakers from Acuitas Therapeutics, Thermo Fisher Scientific, Element Biosciences, and Cooley examine the risks and implications of obviousness-type double patenting and offer guidance for mitigating its impact on innovation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026   Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.
Americas
J&J unit targets former employee over alleged mass data theft
17 March 2026   Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.
Americas
Mylan withdraws defence claims against Novo in Wegovy dispute
13 March 2026   A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable.


Editor's picks

Masimo convinces judge that Apple took secrets—but it’s not enough
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

Editor's picks

Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026
Americas
LSPN Awards 2026 finalists revealed
2 March 2026
Americas
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
26 February 2026
Americas
Eli Lilly escapes $278m payout in biotech licensing dispute
26 February 2026
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026

More features

Part II: The race to replace semaglutide heats up
Part I: Ozempic goes generic as Novo’s key patent expires
Masimo convinces judge that Apple took secrets—but it’s not enough
Sandoz strikes fresh biosimilar deal with South Korean biotech
US firm boosts patent bench with Desmarais hire
J&J unit targets former employee over alleged mass data theft
HSF Kramer hires patent litigator as partner in Germany
INTA: ‘New normal’ for in-house counsel as budgets fall